Clinical Trials Browser

Phase 2 × COVID-19 × Clear all

NCT05672355 2026-05-20

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

Phase 2 Suspended

LymphoidOther hematologic neoplasm

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04977024 2026-02-11

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

Phase 2 Active not recruiting

LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Multiple Myeloma

NCT04761822 2025-08-12

SARS

Phase 2 Completed

746 enrolled 28 charts

COVID-19, Hypersensitivity, Mastocytosis, Severe Acute Respiratory Syndrome

NCT04377659 2025-05-28

Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection

Phase 2 Terminated

9 enrolled 8 charts

COVID-19, Respiratory Tract Infections

NCT04347226 2025-05-22

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

Phase 2 Terminated

43 enrolled 14 charts

Other hematologic neoplasm

COVID-19, Coronavirus Infections, Hematologic Neoplasms

NCT04379492 2025-05-16

A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19

Phase 2 Withdrawn

COVID-19

NCT04466098 2025-01-29

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Phase 2 Completed

8 enrolled 21 charts

Cytokine Release Syndrome, COVID-19, Lymphoma, Follicular, Respiratory Distress Syndrome

NCT05016622 2024-07-31

Booster Dose Trial

Phase 2 Terminated

106 enrolled 39 charts

COVID-19, Neoplasms

NCT04404361 2024-06-05

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

Phase 2 Terminated

200 enrolled 16 charts

COVID-19

NCT04426201 2024-04-11

ILIAD-7-US-O

Phase 2 Terminated

COVID-19, Lymphopenia

NCT05465876 2024-04-04

PACE-CLL

Phase 2 Withdrawn

LymphoidOther hematologic neoplasm

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05125562 2024-02-13

Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19

Phase 2 Withdrawn

COVID-19, Lymphoma, Follicular

NCT04358406 2023-11-28

Rhu-pGSN for Severe Covid-19 Pneumonia

Phase 2 Completed

64 enrolled 17 charts

Cytokine Release Syndrome, COVID-19, Lymphoma, Follicular, Pneumonia

NCT05393999 2023-04-24

SABRE

Phase 2 Withdrawn

LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Leukemia, Lymphoma, Purpura, Thrombotic Thrombocytopenic, Purpura, Thrombocytopenic, Idiopathic, Neoplasms, Plasma Cell

NCT04733833 2023-02-01

A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19

Phase 2 Completed

COVID-19, Lymphoma, Follicular

NCT05371275 2022-11-07

CDK6COV

Phase 2 Withdrawn

COVID-19, Lymphoma, Follicular

NCT04333914 2022-09-30

IMMUNONCOVID

Phase 2 Completed

COVID-19, Infections, Neoplasms

NCT04447235 2022-08-09

TITAN

Phase 2 Terminated

COVID-19, Neoplasms, Coronavirus Infections

NCT03944447 2022-06-02

OMNI-Can

Phase 2 Unknown

200,000 enrolled

Classical hematology

Chronic Traumatic Encephalopathy, Brain Injuries, Traumatic, COVID-19, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Autistic Disorder, Bipolar Disorder, Colitis, Ulcerative, Crohn Disease, Depression, Epilepsy, Fibromyalgia, Tourette Syndrome, Glaucoma, Hepatitis C, Sleep Initiation and Maintenance Disorders, Multiple Sclerosis, Opioid-Related Disorders, Neoplasms, Parkinson Disease, Seizures, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Coronavirus Infections, Severe Acute Respiratory Syndrome, Chronic Pain

NCT04453384 2022-03-25

POLYCOR

Phase 2 Completed

COVID-19, Lymphoma, Follicular, Pneumonia, Severe Acute Respiratory Syndrome

NCT04381988 2021-10-27

A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy

Phase 2 Terminated

4 enrolled 5 charts

COVID-19, Neoplasms

NCT04392128 2020-09-04

HYACINTHE

Phase 2 Withdrawn

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT04341207 2020-04-10

ONCOVID

Phase 2 Unknown

COVID-19, Neoplasms